Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Found this to be great
Milestone Payments - The Company has entered into a number of licensing agreements with suppliers and universities that will require payments to be made to them in future years, based on the achievement by the Company of certain milestones and which payments could total up to $897,500. Subsequently, following commercialization, royalty payments will be required, based on a percentage of annual net sales of the licensed product, in the range of 4% to 6% per royalty agreement.
Licensing Agreements - The Company has entered into a number of licensing agreements with educational and medical institutions as well as suppliers, with regard to intellectual property to be incorporated into the SPORT Surgical System. These agreements require Titan to make periodic payments in 2017 and beyond.
On June 8, 2015, the Company entered into an option agreement with Platform Imaging, LLC (“Platform”) whereby Platform granted the Company an option to negotiate a license agreement to have exclusive rights to practice the inventions set forth in patents and patent applications for markerless tracking of robotic surgical tools for potential incorporation in the SPORT Surgical System and to distribute such product thereafter. Under the terms of the option agreement, the Company paid to Platform a non-refundable option fee of $300,000 as follows: (i) $100,000 upon signing the option agreement; (ii) $100,000 on January 2, 2016; and (iii) $100,000 on October 1, 2016. In addition, the Company had the right at any time up to and including February 2, 2017, to exercise the option by paying a fee of $1.3 million for the rights under the license agreement, payable upon execution of a license agreement. Titan has given written notice that it does not intend to exercise the option.
Big20 who bought 620k
Two ways to play this .
This is our bottom and recognize this pps as a gift temporarily
or
disbelieve and sell your shares at an all time low
Shorts are motivated by failure
longs motivated by sound science sound economics sound healthcare professionals sound intellectual property.
This is the storm where 100 people start on ship but 50 or less decide to weather
If you've weathered a 30k loss, you've lasted a harsh four year waters, and you hold shares at a pps at four times plus current pps I encourage you to hold
I went to school for information science, my older sister is a doctor of immunology and taught at Columbia and recently left for Johnson and Johnson. I was told by a very successful investor about Titan four years ago, and then again by a med rep that works with John valvo. Dr Fowler is one of the most respected surgeons in his field and if you watch any of the annual conferences he speaks with conviction about a market place that has been untapped and like a stud knows that his baby changes the parameters and scope of robotics. The best part about this technology is its adaptability to take on the most complex scenarios with unprecedented advantages.
What came first the chicken or the egg? New investors should watch Fowler over 2 to 3 years ago speak about fundamentals behind sport. Irony is a year later a company verbatim talks the same story
Fowler is on video long before Scott telling the same story, we are the author behind this ending... hold on
That's BS in NY making trades like a baller shot caller, no problem with trades
Within 5 years there will be a robot in almost every OR in the USA and most of the developed world.
Titan/sport will have a place somewhere.
PT I'm slow Pacific Time
Has the presentation started?
A Men! BIG DAY TITAN
Adrock you sure about that?? Page 11 4th paragraph down
Based on the evolution of the SPORT design, the creation and refinement of software for production system functionality has not yet commenced. As the system design matures early in the year, the Company plans to commence this process in the first half of 2017, and anticipates that it will continue as an intensive, ongoing process through the balance of 2017 with anticipated completion in 2018. As software development is a parallel effort, it is anticipated that insights gained from human factors and pre-clinical studies will provide opportunities to optimize the system for clinical use.
Rocko please provide the patent that shows the patent attorney representing Titan and also please provide the patent that the same up attorney helped sri/verb
Bristol19 do you have any connections to an alias that has been shorting this stock called seeyouintheloo?
No Idea, googled C W V W robotic surgery and this was the first document I saw
I'd think if verb was in play we would see higher then 5 pps, onvo went from a dollar to over 10 on the otc a few years back
Even if turns into cannabis play?
Looks like some one sold 88 k shares today, they clearly don't believe verb is in play
This a good private placement raise for longs, just questions the amount, very low
The placement involves the sale of up to 650,000 units at a price of $0.34 per unit. Each unit comprises one common share and one share purchase warrant. Each warrant will entitle the holder to purchase a further common share at $0.40 for a period of 36 months from closing.
Quantitative Equity Report on TITXF
Posted 2/9/17
https://www.otcmarkets.com/common/showMorningstarReport?symbol=TITXF
Let's not forget the Dennis Fowler Andrea Bajo Nabil Simaan connection from IREP Columbia/Vanderbilt
https://engineering.vanderbilt.edu/news/2013/nautilus-team’s-tiny-robot-called-medical-science-breakthrough/
http://roboticsalley.org/2015-speakers/
JOSUE VILLALTA
Knobbe Martens Olson & Bear LLP
DENNIS FOWLER, MD, MPH
Titan Medical
MICHAEL PEREIRA
Ximedica
Dominant robotic surgery patents expiring this year. So what’s Next?
By AMANDA CICCATELLI – August 23, 2016
Patents are essential to encouraging innovation, but can also limit competition. Intuitive Surgical has dominated the global robotic surgery market (which is expected to hit $11.4 billion by 2020) since the FDA approved its Da Vinci surgical system 16 years ago; today, the machine is used in more than 200,000 operations annually. But many of Intuitive Surgical’s patents begin to expire this year, clearing the way for new technologies to enter the marketplace.
Newcomers include TransEnterix, which is working to commercialize the ALF-X robot, designed to perform minimally invasive surgeries and expected to enter the market in 2017. Google’s Verily, meanwhile, has partnered with Johnson & Johnson to form Verb Surgical, a robotic surgery and medical device that aims to go beyond robotics to what CEO Scott Huennekens calls “digital surgery” — incorporating advanced visualization, instrumentation and analytics.
Josue Villalta of Knobbe Martens recently sat down with Inside Counsel to explore how the patent system has impacted development and innovation in the robotic surgery space and how the expiration of Intuitive Surgical’s patents is expected to impact the marketplace.
The patent system has allowed innovators in the robotic surgery space the ability to protect their innovations while excluding others from practicing the innovations covered by their patents, and in turn, providing barriers to entry into the market for potential competitors. “This is particularly important given that robotic surgical systems are very complex systems that take years to develop, in addition to having to go through an FDA approval process before they can be used in the U.S.,” he explained.
The main player in the robotic surgery space has been Intuitive Surgical, which a search of the public USPTO assignment database indicates has 649 U.S. patents. According to Villalta, however, this number does not capture patents that Intuitive Surgical may have rights to, so the number of patents Intuitive Surgical may have that cover its technology may be much higher.
http://www.orthospinenews.com/dominant-robotic-surgery-patents-expiring-this-year-so-whats-coming-next/
Pretty impressive Ip law firm
FIRM RANKINGS & RECOGNITION
https://www.knobbe.com/about/rankings
Managing Intellectual Property (MIP) Firm of the Year 2015 Trademark Contentious
Recognized Among Top Trademark Law Firms in U.S. and California in 2017 "World Trademark Review 1000"
January 17, 2017 | Litigation | Prosecution | Trademarks | National | Regional | World Trademark Review (WTR)
Ranked a Top 10 Law Firm for Diversity and Business in the 2016 "Do Good, Do Well List" by Minority Corporate Counsel Association (MCCA)
December 21, 2016 | National | Minority Corporate Counsel Association (MCCA)
Named "Intellectual Property Law Firm of the Year - USA" in the "Legal Awards 2016"
December 13, 2016 | National | Lawyer Monthly Magazine
Ranked Among 2017 "Best Law Firms" by U.S. News & World Report and Best Lawyers
November 1, 2016 | Litigation - Patent (Metropolitan Tier 1; National Tier 1) | Litigation - Intellectual Property (Metropolitan Tier 1; National Tier 3) | Patents (Metropolitan Tier 1; National Tier 1) | Trademarks (Metropolitan Tier 1) | Information Technology Law (National Tier 3) | U.S. News & World Report and Best Lawyers
Recognized in Legal Media Group's (LMG) "Life Sciences Survey"
October 24, 2016 | Hatch-Waxman Litigation | Patent Litigation | Patent Prosecution | Patent Strategy & Management | National | Legal Media Group (LMG)
Ranked No. 1 Most Recommended Law Firm in San Diego for Intellectual Property
August 10, 2016 | Patent | Regional | Our City San Diego
Ranked Among Top 15 Overall Busiest Firms in Corporate Counsel "Patent Litigation Survey"
July 15, 2016 | Patent Litigation | National | Corporate Counsel
Ranked Top Intellectual Property Boutique Law Firm in 2017 "Best Law Firms" Practice Area Rankings
July 6, 2016 | Vault
Ranked in The Legal 500 "United States 2016"
June 23, 2016 | Patent Licensing | Patent Litigation | Patent Prosecution | Trademarks | National | The Legal 500
Received "Best USA IP Firm" Award for Patent Prosecution and Trademarks from International Legal Alliance Summit & Awards
June 22, 2016 | International | Leaders League
Ranked Among Top 20 Firms Worldwide for Intellectual Property in the 2016 "Who's Who Legal 100" List
June 15, 2016 | International | Who's Who Legal (WWL)
Ranked Top 10 for Overall Diversity on AmLaw "Diversity Scorecard"
June 1, 2016 | Diversity | National | The American Lawyer
Ranked a Top Law Firm for Patent Prosecution in California and Recognized for Life Sciences in "Chambers USA 2016"
May 27, 2016 | Patent Prosecution | Life Sciences | Regional | Chambers & Partners
Ranked Nationally and in California and Seattle as a Leading Law Firm for Patent Prosecution, Transactions and Litigation in "IAM Patent 1000" Guide
May 23, 2016 | Prosecution | Transactions | Litigation | National | Regional | Intellectual Asset Management (IAM) Magazine
Recognized Nationally and Regionally in Managing IP's 2016 "IP Stars" Handbook
May 18, 2016 | Bio Life Sciences | Patent Contentious | Patent Prosecution | Trademark Contentious | Trademark Prosecution | PTAB Litigation | National | Regional | Managing Intellectual Property (MIP)
Ranked Top 15 in “100 Best Law Firms for Minority Attorneys”
May 16, 2016 | Diversity | National | Law360
Ranked #3 Largest IP Boutique Firm in 2016 by Law360
March 25, 2016 | National | Law360
Named a Top Patent Prosecution Firm in Managing IP 2016 "North America Awards"
March 18, 2016 | Prosecution | National | Regional | Managing Intellectual Property (MIP)
Ranked Among Top 5 "Largest IP Practice Groups" by Law360
November 16, 2015 | National | Law360
Ranked Among Top 5 Firms Nationwide and Top 10 Firms Globally for Number of PCT Application Filings in MIP's "2015 PCT Survey"
September 24, 2015 | Patents | National | International | Managing Intellectual Property (MIP)
Received "Patent Impact Case of the Year" Award in "LMG Life Sciences Annual Awards"
September 16, 2015 | Litigation | Patents | National | Legal Media Group (LMG)
Named "Most Outstanding Copyright Law Firm - USA" and "IP Law Team of the Year - California" in 2015 "M&A Awards" by Corporate LiveWire
June 8, 2015 | National | Regional | Corporate LiveWire
Ranked Among Top 15 Firms in The National Law Journal's (NLJ) 2015 “Intellectual Property Hot List”
May 29, 2015 | National | The National Law Journal (NLJ)
Ranked Top Ten Nationally for Quality Patents in IAM/Ocean Tomo PatentRatings® Survey
April 27, 2015 | Patents | Industrials | Consumer Electronics | Healthcare | Information Technology | National | Intellectual Asset Management (IAM) Magazine & Ocean Tomo
Ranked Among Top 10 Firms Nationwide for Number of Utility Patents Issued in IP Today's 2015 "Top Patent Firms" List
March 30, 2015 | Patents | National | Intellectual Property Today (IP Today)
Named "2015 Litigation Department of the Year" for Intellectual Property by The Recorder
March 6, 2015 | Litigation | Regional | The Recorder
ATTORNEY RECOGNITION
Susan Natland recognized as the exclusive winner of the 2017 "Client Choice Award" in the IP: Trademarks, California category
February 9, 2017 | Attorney: Natland | International Law Office (ILO)
John Sganga and Jonathan Hyman Recognized in the 2017 BTI "Client Service All-Stars" Report
February 7, 2017 | Attorneys: Sganga, Hyman | BTI Consulting Group
Twenty Knobbe Martens Attorneys Named 2017 "Southern California Super Lawyers"
January 20, 2017 | Litigation | Patents | Trademarks | Attorneys: Cianfrani, Friedland, Gurka, Holcomb, Hyman, Jennings, Katzenellenbogen (Ben), King, Larson, Lateef, Lee (Sabing), Nataupsky, Natland, Re, Sganga (John), Stewart, Summers, Swaroop, von Hoffmann, Vogel Weil | Regional | Super Lawyers
Fred Berretta, Michael Fuller, and Boris Zelkind Named 2017 "San Diego Super Lawyer"
January 20, 2017 | Litigation | Patents | Regional | Super Lawyers
Benjamin Anger and Maria Stout Named 2017 "San Diego Rising Star"
January 20, 2017 | Litigation | Patents | Regional | Super Lawyers
Catherine Holland, Susan Natland, Gregory Phillips, Diane Reed, Jeff Van Hoosear, Jonathan Hyman, and Lynda Zadra-Symes Recognized as The World's Leading Trademark Professionals in 2017 "WTR 1000"
January 17, 2017 | Litigation | Prosecution | Trademarks | Attorneys: Holland, Natland, Phillips, Reed, Van Hoosear, Hyman, Zadra-Symes | National | World Trademark Review (WTR)
Five Knobbe Martens Attorneys Recognized in 2017 "Who's Who Legal: Patent" List
January 12, 2017 | Attorneys: Altman, Bunker, Re, Zadra-Symes, Zimmerman | International | Who's Who Legal (WWL)
Michael Fuller Named to San Diego Business Journal's "SD500" List
December 12, 2016 | National | San Diego Business Journal (SDBJ)
Steven Nataupsky and Wendy Peterson Named to Orange County Business Journal's "OC500" List
November 15, 2016 | National | Orange County Business Journal (OCBJ)
Twelve Knobbe Martens Attorneys Recognized as "Life Science Stars" by LMG Life Sciences
October 24, 2016 | Litigation | Patents | Licensing | IP Strategy | Attorneys: Altman, Israelsen, Lea, Lee (Sabing), Mallon, Martens, Merani, Miller, Re, Reisman, von Hoffmann, Zimmerman | National | Legal Media Group (LMG)
Salima Merani and William Zimmerman Received Top Honors in the 2016 "LMG Life Sciences Annual Awards"
September 15, 2016 | Litigation | Patents | Attorney: Merani, Zimmerman | National | Legal Media Group (LMG)
Susan Natland and Lynda Zadra-Symes Named to Legal Media Group's "Women in Business Law" Guide
August 19, 2016 | Trademarks | Attorneys: Natland, Zadra-Symes | International | Legal Media Group (LMG)
Five Knobbe Martens Attorneys Named Among "Top IP Lawyers in California "
August 17, 2016 | Attorneys: Babcock, Merani, Natland, Re, Sganga (John) | Litigation | Patents | Daily Journal
Seventeen Knobbe Martens Attorneys Recognized Among The Best Lawyers in America© 2017
August 15, 2016 | Litigation | Patents | Trademarks | Copyrights | Trade Secrets | Information Technology | Technology| Attorneys: Anderson, Berretta, Bunker, Carson, Cianfrani, Israelsen, Nataupsky, Pitzel Cruz, Re, Reisman, Rose, Seelig, Sganga (John), Uribe, Vogel Weil, Zadra-Symes, Zelkind | National | Best Lawyers®
Dr. Salima Merani Named in 2016 "Women Leaders in Tech Law"
July 29, 2016 | Regional | The Recorder
Eight Knobbe Martens Attorneys Named in "Who's Who Legal:Trademarks 2016"
June 15, 2016 | Trademarks | Attorneys: Halpern, Holland, Hyman, Natland, Reed, Simpson, Van Hoosear, Zadra-Symes| International | Who's Who Legal
Eleven Knobbe Martens Attorneys Named 2016 "Southern California Rising Stars"
June 7, 2016 | Litigation | Patents | Trademarks | Attorneys: Armond, Bunker (Jared), Burgess, Claasen, Hsu, Kahf, Katzenellenbogen (Lauren), Phillips, Razai, Ross, Wahl | Regional | Super Lawyers
Paul Stewart Recognized in the 2016 "Intellectual Property Trailblazer" list
May 31, 2016 | Attorney: Stewart | The National Law Journal (NLJ)
Salima Merani, Joseph Re, and Gerard von Hoffman Recognized in "Chambers USA 2016"
May 27, 2016 | Litigation | Patents | Attorneys: Merani, Re, von Hoffmann | Regional | Chambers & Partners
Twenty-Three Knobbe Martens Attorneys Named The World's Leading Patent Professionals in the 2016 "IAM Patent 1000" Guide
May 26, 2016 | Post-Grant Procedures | Court of Appeals for the Federal Circuit | Prosecution | Transactions | Litigation | Attorneys: Akhtar, Anderson, Babcock, Benedict, Carson, Gurka, Hart, Israelsen, King, Lateef, Loots, Mallon, Merani, Miller, Re, Reisman, Rose, Schoenbaum, Seelig, Sganga (John), Uribe, Weil, Zimmerman | National | Regional | Intellectual Asset Management (IAM)
Eight Knobbe Martens Attorneys Recognized as Top IP Practitioners in Managing IP's "IP Stars" Handbook
May 18, 2016 | Litigation | Patents | Trademarks | Attorneys: Anderson (Maria), Bunker (William), Gurka, Jensen, Re, Roby, Rose, Zimmerman | National | Managing Intellectual Property (MIP)
Maria Anderson, Salima Merani and Karen Vogel Weil Recognized in "2016 Women in Law Awards"
May 5, 2016 | Attorneys: Anderson, Salima, Weil | National | Lawyer Monthly Magazine
Bill Zimmerman Named 2016 "Washington D.C. Super Lawyer" by Super Lawyers Magazine
April 25, 2016 | Litigation | Patents | Attorney: Zimmerman | Regional | Super Lawyers
Jonathan Bachand Named 2016 "Washington D.C. Rising Star" by Super Lawyers Magazine
April 25, 2016 | Litigation | Patents | Attorney: Bachand | Regional | Super Lawyers
Jeff Van Hoosear, Joseph Re, and Susan Natland Named 2016 "World IP Leader" by World IP Review
April 22, 2016 | Patents | Trademarks | Attorneys: Van Hoosear, Re, Natland | World IP Review (WIPR)
Joseph Re Named "Icon of IP" in Law360's List of 25 Most Influential Attorneys
January 24, 2016 | Attorney: Re | Law360
Why does the moderator delete relevant posts? Fly what did you say?
Please share the ip attorney your referring too, also did note that on linked in Andrea Bajo is one of my connections and I saw that he is all ready connected to our Newly appointed VP .... another coincidence maybe / maybe not
Unload post shelf? Then wait thirty days and reinvest?
Spectra Science trading at .001 on otc
http://www.otcmarkets.com/stock/SCIE/profile
Dr. Perry A. Genova, Ph.D., serves as Chief Executive Officer and President of Oncoscope, Inc
Oncoscope inc - Bankrupt ?
https://businessbankruptcies.com/cases/oncoscope-inc
Down 19k what's another 10, thanks for the warning Mensa
Disagree, i know of top talent CEO's that invest in their companies at low and high levels because they believe it's a good place to park their money. Look at dr frost for instance, he says it best "how can I expect investors to invest in my company if I'm not an investor myself" selling shares is not a conspiracy it's a lack of confidence in your investment I will sit on the sidelines and watch this until sustained revenues are tangible
50k stock bonus is great, however if your long and believe in the 20% efficiency and future revenues wouldn't you wait for a stronger return? Is he hard on for $$, or does he know something we don't??
How many shares total does this dude got? If he has millions then I get it why he sold a lil, but I'm thinking ultimately not a good sign, you flip around that sell and he's buying 100k shares and we gotta a confident management team
Natcore Technology logoNatcore Technology Inc (TSE:NXT) Director William John Meekison sold 100,000 shares of the business’s stock in a transaction dated Thursday, January 12th. The stock was sold at an average price of C$0.44, for a total value of C$44,000.00.
William John Meekison also recently made the following trade(s):
On Friday, January 13th, William John Meekison sold 30,000 shares of Natcore Technology stock. The stock was sold at an average price of C$0.45, for a total value of C$13,500.00.
He got me jacked up, I like how he described Titan as "an opportunity of a lifetime" strong verbal advantage, I'm buying more shares in three days, this stock has been a huge let down so far to me personally, and currently down over 10k, but I believe that will be short lived, LET GO TITAN
I live in Rochester NY and work a stones throw from water street, like the ip, parents, and technology. Not a big fan of lack of revenue but will keep my eye on this
Anyone else see a correlation between verbs and titans benefits and features?
Granted no longer with the company but Fowler would talk about the exact same advantages that huennekens touts verbs platform to this day.
It's like they mirror each other verbatim
Ie smaller footprint in the OR, cost-effectiveness, advanced visualization, data analytics etc